Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8165) 8165
Newsletter (246) 246
Book Chapter (226) 226
Newspaper Article (118) 118
Magazine Article (80) 80
Conference Proceeding (16) 16
Dissertation (14) 14
Publication (11) 11
Book / eBook (10) 10
Reference (3) 3
Government Document (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6662) 6662
polycythemia vera (2995) 2995
male (2909) 2909
science & technology (2885) 2885
life sciences & biomedicine (2829) 2829
female (2768) 2768
middle aged (2504) 2504
aged (2053) 2053
adult (1840) 1840
hematology (1720) 1720
polycythemia (1612) 1612
polycythemia vera - complications (1451) 1451
biological and medical sciences (1190) 1190
medical sciences (1171) 1171
old medline (1083) 1083
polycythemia vera - blood (1059) 1059
polycythemia vera - genetics (1012) 1012
polycythemia vera - diagnosis (963) 963
hematologic and hematopoietic diseases (901) 901
abridged index medicus (846) 846
polycythemia vera - drug therapy (819) 819
janus kinase 2 - genetics (816) 816
polycythemia vera - pathology (792) 792
mutation (776) 776
polycythemia vera - therapy (760) 760
oncology (726) 726
aged, 80 and over (601) 601
essential thrombocythemia (601) 601
leukemia (502) 502
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (488) 488
diseases of red blood cells (482) 482
diagnosis, differential (478) 478
myelofibrosis (477) 477
polycythemias (462) 462
research (434) 434
animals (423) 423
hematocrit (419) 419
risk factors (386) 386
adolescent (379) 379
thrombocythemia, essential - genetics (365) 365
myeloproliferative disorders - genetics (360) 360
care and treatment (359) 359
thrombosis (359) 359
myeloproliferative disorders (358) 358
tumors (358) 358
hemic and lymphatic diseases (350) 350
prognosis (346) 346
bone marrow - pathology (331) 331
primary myelofibrosis (330) 330
primary myelofibrosis - genetics (317) 317
general & internal medicine (297) 297
medicine, general & internal (294) 294
polycythemia vera - physiopathology (284) 284
genetic aspects (278) 278
janus kinase 2 (278) 278
polycythemia - diagnosis (277) 277
diagnosis (276) 276
hydroxyurea - therapeutic use (266) 266
bone marrow (263) 263
polycythemia vera - metabolism (254) 254
primary myelofibrosis - pathology (248) 248
myeloproliferative neoplasms (244) 244
analysis (241) 241
polycythemia vera - etiology (241) 241
retrospective studies (240) 240
treatment outcome (237) 237
erythropoietin (235) 235
phlebotomy (233) 233
medical research (231) 231
polycythemia - blood (231) 231
follow-up studies (226) 226
blood (223) 223
child (223) 223
chronic disease (222) 222
patients (221) 221
medicine & public health (220) 220
polycythemia vera - enzymology (215) 215
myeloproliferative disorders - diagnosis (214) 214
erythropoiesis (213) 213
polycythaemia vera (213) 213
antineoplastic agents - therapeutic use (210) 210
primary myelofibrosis - diagnosis (208) 208
medicine, experimental (207) 207
erythrocytes (206) 206
hydroxyurea (206) 206
polycythemia - etiology (206) 206
myeloproliferative disorders - pathology (203) 203
thrombosis - etiology (203) 203
thrombocythemia, essential - diagnosis (201) 201
mice (200) 200
pathology (200) 200
anemia (199) 199
blood cell count (199) 199
polycythemia vera - radiotherapy (199) 199
thrombocythemia, essential - pathology (196) 196
thrombocythemia, essential - drug therapy (185) 185
erythropoietin - blood (183) 183
health aspects (182) 182
jak2 (182) 182
time factors (181) 181
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7041) 7041
German (447) 447
French (386) 386
Russian (294) 294
Italian (178) 178
Japanese (178) 178
Spanish (114) 114
Polish (101) 101
Hungarian (58) 58
Chinese (42) 42
Portuguese (33) 33
Romanian (31) 31
Korean (29) 29
Czech (28) 28
Danish (24) 24
Dutch (21) 21
Swedish (18) 18
Turkish (14) 14
Hebrew (10) 10
Norwegian (10) 10
Slovak (9) 9
Finnish (6) 6
Serbian (6) 6
Bulgarian (4) 4
Ukrainian (4) 4
Croatian (3) 3
Afrikaans (1) 1
Indonesian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Polycythemia Vera
by Spivak, Jerry L
Current treatment options in oncology, ISSN 1527-2729, 2/2018, Volume 19, Issue 2, pp. 1 - 14
Medicine & Public Health | JAK2 V617F | Oncology | Polycythemia vera | Diagnosis | Management | Natural history | Life Sciences & Biomedicine | Science & Technology | Leukocytosis - complications | Splenomegaly - complications | Thrombocytosis - complications | Humans | Hematocrit | Janus Kinase 2 - genetics | Thromboembolism - complications | Polycythemia Vera - genetics | Polycythemia - complications | Polycythemia Vera - etiology | Polycythemia Vera - physiopathology | Care and treatment | Chemotherapy | Usage | Polycythemia | Leukemia | Hemoglobin | Thromboembolism | Health aspects | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Macrophages support pathological erythropoiesis in polycythemia vera and beta-thalassemia
by Ramos, P and Casu, C and Gardenghi, S and Breda, L and Crielaard, B.J and Guy, E and Marongiu, M.F and Gupta, R and Levine, R.L and Abdel-Wahab, O and Ebert, B.L and van Rooijen, N and Ghaffari, S and Grady, R.W and Giardina, P.J and Rivella, S
Nature medicine, ISSN 1078-8956, 2013, Volume 19, Issue 4, pp. 437 - 445
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Macrophages - physiology | Stress, Physiological - physiology | Reticulocytes - physiology | Clodronic Acid - pharmacology | Humans | Mice, Inbred C57BL | Hematocrit | beta-Thalassemia - physiopathology | Erythropoiesis - drug effects | Male | Erythropoiesis - physiology | Animals | Female | Macrophages - drug effects | Mice | Erythrocyte Count | Hemoglobins - analysis | Polycythemia Vera - physiopathology | Disease Models, Animal | Erythropoiesis | Regulators | Animal models | Erythropoietin | Anemia | Erythrocytes | Thalassemia | Polycythemia vera | Macrophages | Enucleation | Organic chemistry | Erythroblasts | Polycythemia | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera
by Vannucchi, Alessandro M and Kiladjian, Jean Jacques and Griesshammer, Martin and Masszi, Tamas and Durrant, Simon and Passamonti, Francesco and Harrison, Claire N and Pane, Fabrizio and Zachee, Pierre and Mesa, Ruben and He, Shui and Jones, Mark M and Garrett, William and Li, Jingjin and Pirron, Ulrich and Habr, Dany and Verstovsek, Srdan
The New England journal of medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 5, pp. 426 - 435
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pyrazoles - therapeutic use | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Antineoplastic Agents - therapeutic use | Spleen - drug effects | Thrombocytopenia - chemically induced | Remission Induction | Blood Cell Count | Janus Kinases - antagonists & inhibitors | Organ Size - drug effects | Hydroxyurea - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Hydroxyurea - therapeutic use | Polycythemia Vera - drug therapy | Aged | Spleen - pathology | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Spleen | Thrombocytopenia | Splenomegaly | Herpes zoster | Inhibitor drugs | Hematocrit | Polycythemia vera | Hydroxyurea | Thrombosis | Patients | Side effects | Polycythemia | Janus kinase | Remission | Blood diseases | Thromboembolism | Drug therapy | Drug dosages | Nuclear magnetic resonance--NMR | Phlebotomy | Restless legs syndrome | Cancer | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
by Marchioli, Roberto and Finazzi, Guido and Specchia, Giorgina and Cacciola, Rossella and Cavazzina, Riccardo and Cilloni, Daniela and De Stefano, Valerio and Elli, Elena and Iurlo, Alessandra and Latagliata, Roberto and Lunghi, Monia and Lunghi, Francesca and Marfisi, Rosa Maria and Musto, Pellegrino and Masciulli, Arianna and Musolino, Caterina and Cascavilla, Nicola and Quarta, Giovanni and Randi, Maria Luigia and Rapezzi, Davide and Ruggeri, Marco and Rumi, Elisa and Scortechini, Anna Rita and Santini, Simone and Scarano, Marco and Siragusa, Sergio and Spadea, Antonio and Tieghi, Alessia and Angelucci, Emanuele and Visani, Giuseppe and Vannucchi, Alessandro Maria and Barbui, Tiziano and CYTO-PV Collaborative Grp and CYTO-PV Collaborative Group
The New England journal of medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 1, pp. 22 - 33
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Polycythemias | General aspects | Diseases of red blood cells | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Cardiovascular Diseases - etiology | Follow-Up Studies | Humans | Middle Aged | Hematocrit | Phlebotomy | Polycythemia Vera - blood | Male | Thrombosis - epidemiology | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Polycythemia Vera - therapy | Janus Kinase 2 | Polycythemia Vera - complications | Thrombosis - etiology | Cardiovascular Diseases - mortality | Female | Hydroxyurea - therapeutic use | Aged | Control | Usage | Care and treatment | Causes of | Polycythemia vera | Diagnosis | Cardiovascular diseases | Risk factors | Clinical trials | Medical treatment | Mutation | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text How I treat polycythemia vera
by Spivak, Jerry L
Blood, ISSN 0006-4971, 07/2019, Volume 134, Issue 4, pp. 341 - 352
Life Sciences & Biomedicine | Hematology | Science & Technology | Disease Susceptibility | Humans | Middle Aged | Male | Treatment Outcome | Hematopoietic Stem Cells - metabolism | Polycythemia Vera - therapy | Evidence-Based Medicine | Polycythemia Vera - diagnosis | Polycythemia Vera - metabolism | Hematopoietic Stem Cells - cytology | Aged, 80 and over | Biomarkers | Adult | Female | Combined Modality Therapy - methods | Disease Management | Polycythemia Vera - etiology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text How I treat polycythemia vera
by Vannucchi, Alessandro M
Blood, ISSN 0006-4971, 11/2014, Volume 124, Issue 22, pp. 3212 - 3220
Life Sciences & Biomedicine | Hematology | Science & Technology | Humans | Middle Aged | Janus Kinase 2 - genetics | Polycythemia Vera - blood | Male | Physician-Patient Relations | Polycythemia Vera - genetics | Polycythemia Vera - therapy | Polycythemia Vera - diagnosis | Erythropoietin - blood | DNA Mutational Analysis | Aged | Precision Medicine | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Oral idasanutlin in patients with polycythemia vera
by Mascarenhas, John and Lu, Min and Kosiorek, Heidi and Virtgaym, Elizabeth and Xia, Lijuan and Sandy, Lonette and Mesa, Ruben and Petersen, Bruce and Farnoud, Noushin and Najfeld, Vesna and Rampal, Raajit and Dueck, Amylou and Hoffman, Ronald
Blood, ISSN 0006-4971, 08/2019, Volume 134, Issue 6, pp. 525 - 533
Life Sciences & Biomedicine | Hematology | Science & Technology | Proto-Oncogene Proteins c-mdm2 - genetics | Administration, Oral | Humans | Middle Aged | Pyrrolidines - administration & dosage | Pyrrolidines - adverse effects | Male | Treatment Outcome | Antineoplastic Agents - administration & dosage | Molecular Targeted Therapy | Polycythemia Vera - diagnosis | para-Aminobenzoates - administration & dosage | Antineoplastic Agents - adverse effects | para-Aminobenzoates - adverse effects | Aged, 80 and over | Biomarkers | Adult | Female | Polycythemia Vera - drug therapy | Aged | Mutation | Polycythemia Vera - etiology | Proto-Oncogene Proteins c-mdm2 - antagonists & inhibitors | Proto-Oncogene Proteins c-mdm2 - metabolism | Index Medicus | Abridged Index Medicus | 33 | 8 | Clinical Trials and Observations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights